AU Patent

AU2011202787B2 — Method and composition for transdermal drug delivery

Assigned to Acrux DDS Pty Ltd · Expires 2013-02-21 · 13y expired

What this patent protects

Abstract The invention is a transdermal drug delivery composition of at least one physiologically active agent (e.g. buspirone or fentanyl or androgens such as testosterone), at least one volatile solvent (e.g. isopropanol or ethanol), and at least one viscosity modulating agent …

USPTO Abstract

Abstract The invention is a transdermal drug delivery composition of at least one physiologically active agent (e.g. buspirone or fentanyl or androgens such as testosterone), at least one volatile solvent (e.g. isopropanol or ethanol), and at least one viscosity modulating agent (e.g. PVP), preferably with a penetration enhancer (such as octisalate), which is preferably applied to the axilla. C :fOnnrSPEC-917199.doc JOL

Drugs covered by this patent

Patent Metadata

Patent number
AU2011202787B2
Jurisdiction
AU
Classification
—
Expires
2013-02-21
Drug substance claim
No
Drug product claim
No
Assignee
Acrux DDS Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.